Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Dovjak, P; Sommeregger, U; Otto, R; Roller, RE; Böhmdorfer, B; Iglseder, B; Benvenuti-Falger, U; Lechleitner, M; Gosch, M.
Polypharmacy is of major concern in cardiology].
Wien Med Wochenschr. 2010; 160(11-12): 264-269.
Doi: 10.1007/s10354-010-0784-3
(- Case Report)
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Lechleitner Margarete
-
Roller-Wirnsberger Regina
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
Quality improvement in cardiology over the past decade focused on management of acute coronary syndrome with invasive and innovative medical therapies, optimizing treatment of congestive heart failure and the development of repair procedures in valvular heart disease. On the other hand cardiologist and the attendant physicians are confronted with changes in the characteristics of patients in the light of demographic facts. Comorbidity and polypharmacy raise the need for clear concepts. Therapeutic and diagnostic tools of geriatric medicine may help in that context.
- Find related publications in this database (using NLM MeSH Indexing)
-
Aged -
-
Aged, 80 and over -
-
Bradycardia - chemically induced
-
Cardiovascular Agents - adverse effects Cardiovascular Agents - therapeutic use
-
Drug Interactions -
-
Drug Therapy, Combination -
-
Frail Elderly -
-
Heart Diseases - drug therapy
-
Humans -
-
Long QT Syndrome - chemically induced
-
Prescription Drugs - adverse effects Prescription Drugs - therapeutic use
-
Syncope - chemically induced
-
Tachycardia - chemically induced